Literature DB >> 10884389

Repression of BRCA1 through a feedback loop involving p53.

T K MacLachlan1, B C Dash, D T Dicker, W S El-Deiry.   

Abstract

The BRCA1 and p53 tumor suppressors have been shown to interact and cooperate to activate transcription of p53-responsive genes. In this study, we show that BRCA1 is initially up-regulated, followed by a reduction to below basal levels in response to treatment with the DNA-damaging agents adriamycin and mitomycin C, and that the reduction of BRCA1 expression is dependent on the presence of wild-type p53. Elimination of p53 by expression of human papilloma virus E6 resulted in an inability to down-regulate BRCA1 in response to adriamycin. Ectopic expression of p53 resulted in a rapid decrease in BRCA1 protein and RNA levels and BRCA1 promoter-driven luciferase activity even in null p21 cells deficient in p53-dependent G(1) arrest. ATM(-)(/-) lymphoblastoid cells were deficient in their ability to reduce BRCA1 protein in response to DNA damage, whereas the wild-type counterparts reduced BRCA1 protein levels after exposure to adriamycin. These results, in conjunction with others, suggest a loop wherein BRCA1 initially participates in accumulation of p53 protein, whereas later p53 acts to reduce BRCA1 expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10884389     DOI: 10.1074/jbc.M003338200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  DNA replication blockade impairs p53-transactivation.

Authors:  R Takimoto; W S El-Deiry
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

2.  p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades.

Authors:  L Fang; G Li; G Liu; S W Lee; S A Aaronson
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

3.  BRCA1 directs a selective p53-dependent transcriptional response towards growth arrest and DNA repair targets.

Authors:  Timothy K MacLachlan; Rishu Takimoto; Wafik S El-Deiry
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.

Authors:  Brandon D Jeffy; Jennifer K Hockings; Michael Q Kemp; Sherif S Morgan; Jill A Hager; Jason Beliakoff; Luke J Whitesell; G Timothy Bowden; Donato F Romagnolo
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

5.  BP1, an isoform of DLX4 homeoprotein, negatively regulates BRCA1 in sporadic breast cancer.

Authors:  Brian J Kluk; Yebo Fu; Trina A Formolo; Lei Zhang; Anne K Hindle; Yan-gao Man; Robert S Siegel; Patricia E Berg; Chuxia Deng; Timothy A McCaffrey; Sidney W Fu
Journal:  Int J Biol Sci       Date:  2010-09-10       Impact factor: 6.580

6.  In vitro CO2-induced ROS production impairs cell cycle in SH-SY5Y neuroblastoma cells.

Authors:  Angela Simona Montalto; Monica Currò; Tiziana Russo; Giuseppa Visalli; Pietro Impellizzeri; Pietro Antonuccio; Salvatore Arena; Francesca Astra Borruto; Gianfranco Scalfari; Riccardo Ientile; Carmelo Romeo
Journal:  Pediatr Surg Int       Date:  2013-01       Impact factor: 1.827

7.  Transcriptional autoregulation by BRCA1.

Authors:  Adriana De Siervi; Paola De Luca; Jung S Byun; Li Jun Di; Temesgen Fufa; Cynthia M Haggerty; Elba Vazquez; Cristian Moiola; Dan L Longo; Kevin Gardner
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

Review 8.  One function--multiple mechanisms: the manifold activities of p53 as a transcriptional repressor.

Authors:  Levin Böhlig; Karen Rother
Journal:  J Biomed Biotechnol       Date:  2011-03-08

9.  Are Trp53 rescue of Brca1 embryonic lethality and Trp53/Brca1 breast cancer association related?

Authors:  Kimberly A McAllister; Roger W Wiseman
Journal:  Breast Cancer Res       Date:  2002-02-06       Impact factor: 6.466

10.  Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol.

Authors:  Ilija Androic; Andrea Krämer; Ruilan Yan; Franz Rödel; Regine Gätje; Manfred Kaufmann; Klaus Strebhardt; Juping Yuan
Journal:  BMC Cancer       Date:  2008-12-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.